{"id":"https://openalex.org/W4242706629","doi":"https://doi.org/10.1158/1538-7445.sabcs18-5019","title":"Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity","display_name":"Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4242706629","doi":"https://doi.org/10.1158/1538-7445.sabcs18-5019"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-5019","doi":"https://doi.org/10.1158/1538-7445.sabcs18-5019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-5019","pdf_url":null,"source":{"id":"https://openalex.org/S89865888","display_name":"Immunology","issn_l":"0019-2805","issn":["0019-2805","1365-2567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunology","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023590155","display_name":"Elsa Quintana","orcid":"https://orcid.org/0000-0002-4123-1695","observed_orcids":["https://orcid.org/0000-0002-4123-1695"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elsa Quintana","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085646397","display_name":"Chris J. Schulze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris J. Schulze","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055494036","display_name":"Tiffany J. Choy","orcid":"https://orcid.org/0000-0001-6501-2123","observed_orcids":["https://orcid.org/0000-0001-6501-2123"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany J. Choy","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058734302","display_name":"Darienne R. Myers","orcid":"https://orcid.org/0000-0001-9764-7369","observed_orcids":["https://orcid.org/0000-0001-9764-7369"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darienne R. Myers","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086374199","display_name":"Kasia Mordec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kasia Mordec","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104388930","display_name":"Dylan Daniel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dylan Daniel","raw_affiliation_strings":["MI Bioresearch, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MI Bioresearch, Ann Arbor, MI","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021689661","display_name":"Mark A. Goldsmith","orcid":"https://orcid.org/0000-0001-8833-6841","observed_orcids":["https://orcid.org/0000-0001-8833-6841"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Goldsmith","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056487008","display_name":"Jan A.M. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan A. Smith","raw_affiliation_strings":["Revolution Medicines, Redwood City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Revolution Medicines, Redwood City, CA","institution_ids":["https://openalex.org/I4210100604"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"5019","last_page":"5019"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.023399999365210533,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.8820000290870667},{"id":"https://openalex.org/keywords/allosteric-inhibition","display_name":"allosteric inhibition","score":0.9100000262260437},{"id":"https://openalex.org/keywords/csf1r-signaling","display_name":"CSF1R signaling","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9390000104904175},{"id":"https://openalex.org/keywords/m2-macrophage-polarization","display_name":"M2 macrophage polarization","score":0.878000020980835},{"id":"https://openalex.org/keywords/m1-macrophages","display_name":"M1 macrophages","score":0.8009999990463257},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8389999866485596},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7429999709129333},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8949999809265137},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8410000205039978},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.40400001406669617},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.8330000042915344},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6022840738296509},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5563105940818787},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.5154160261154175},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.48523616790771484},{"id":"https://openalex.org/C2776682551","wikidata":"https://www.wikidata.org/wiki/Q21072584","display_name":"Macrophage polarization","level":4,"score":0.48317021131515503},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.47007113695144653},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.4679970145225525},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4650735855102539},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.4599740505218506},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.44808804988861084},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.43002158403396606},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4274611473083496},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.425359308719635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35039687156677246},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3130947947502136},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2957727313041687},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2829670310020447},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1356969177722931}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-5019","doi":"https://doi.org/10.1158/1538-7445.sabcs18-5019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-5019","pdf_url":null,"source":{"id":"https://openalex.org/S89865888","display_name":"Immunology","issn_l":"0019-2805","issn":["0019-2805","1365-2567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3021048814","https://openalex.org/W2912551658","https://openalex.org/W3180475939","https://openalex.org/W2803801423","https://openalex.org/W4282914015","https://openalex.org/W3089940214","https://openalex.org/W4294011762","https://openalex.org/W2982315700","https://openalex.org/W4313528537","https://openalex.org/W3119111229"],"abstract_inverted_index":{"The":[0,134],"protein-tyrosine":[1],"phosphatase":[2],"SHP2":[3,16,35,171,206,247,264,327,353,395,435],"promotes":[4],"oncogenic":[5],"RAS/MAPK":[6],"pathway":[7],"activation":[8],"in":[9,41,71,79,84,113,121,125,178,201,211,222,233,298,332,336,369],"different":[10],"tumor":[11,39,44,64,81,300,338,386,445],"types.":[12],"In":[13,204,229,286,322],"immune":[14,82,258,312,334,379,387],"cells,":[15,127],"binds":[17],"to":[18,92,141,153,198,281,288,405,449],"phosphorylated":[19],"ITIM":[20],"and":[21,88,123,186,216,253,319,345,396,439],"ITAM":[22],"domains":[23],"on":[24,146,160,172,266,310],"regulatory":[25],"receptors,":[26],"including":[27,314],"PD-1.":[28],"We":[29],"have":[30],"shown":[31],"that":[32,246,282,305,326,390],"RMC-4550,":[33,289],"a":[34,154,164,167,295,329,356,398],"allosteric":[36],"inhibitor,":[37],"attenuates":[38],"growth":[40,65,368],"syngeneic":[42,181],"mouse":[43],"models":[45],"with":[46,58,77,105,118,131,360],"effects":[47,128,309],"equivalent":[48],"to,":[49],"or":[50,194],"greater":[51],"than":[52],"those":[53],"of":[54,97,115,136,156,166,170,176,239,255,263,277,283,316,349,365,376,384,434,443,455],"checkpoint":[55,93,132],"inhibitors.":[56],"Consistent":[57],"anti-tumor":[59,275,378,450],"immunity":[60,162,451],"as":[61,372,374],"the":[62,80,86,95,137,144,157,179,199,236,251,261,267,274,311,337,347,385,456],"mechanism,":[63],"inhibition":[66,207,248,265,354,364,433],"(TGI)":[67],"was":[68,75,101,140,279],"not":[69,129,225,293],"observed":[70],"immunocompromised":[72],"mice.":[73],"TGI":[74],"associated":[76,446],"changes":[78],"microenvironment,":[83],"both":[85,317,341],"adaptive":[87,161,318],"innate":[89,320],"arms.":[90],"Similar":[91],"blockade,":[94,196],"frequency":[96],"CD8+T":[98,191],"cell":[99,192,220,367],"infiltrates":[100],"increased":[102,187],"upon":[103,394],"treatment":[104,232],"RMC-4550.":[106],"Polarized":[107],"macrophage":[108,148],"populations":[109],"were":[110],"significantly":[111,183],"shifted":[112],"favor":[114],"antitumor":[116],"immunity,":[117],"marked":[119],"increases":[120],"M1":[122],"decreases":[124],"M2":[126,444],"seen":[130],"blockade.":[133,285],"objective":[135],"present":[138],"study":[139],"determine":[142],"if":[143],"effect":[145,169,262],"tumor-associated":[147],"(TAM)":[149],"polarization":[150],"is":[151],"secondary":[152],"release":[155],"biochemical":[158],"brakes":[159],"and/or":[163],"result":[165],"direct":[168,363,382],"TAMs.In":[173],"vivo":[174],"administration":[175],"RMC-4550":[177,231,278,306],"CT26":[180,299],"model":[182],"decreased":[184],"M2,":[185,223],"M1,":[188,226],"TAM":[189],"after":[190],"depletion":[193],"IFN\u03b3":[195],"similar":[197,280],"response":[200,380],"control":[202],"animals.":[203],"vitro,":[205],"attenuated":[208],"CSF1R":[209,268,284,437],"signaling":[210,269,438],"murine":[212],"bone":[213],"marrow-derived":[214],"macrophages":[215,447],"selectively":[217,440],"induced":[218],"apoptotic":[219],"death":[221],"but":[224],"polarized":[227],"macrophages.":[228,351],"addition,":[230],"vitro":[234],"reduced":[235],"suppressive":[237,256],"potential":[238],"human":[240],"M-MDSCs.":[241],"Collectively":[242],"these":[243],"observations":[244],"suggest":[245],"directly":[249],"impacts":[250],"survival":[252],"function":[254],"monocytic":[257],"cells.":[259],"Given":[260],"pathway,":[270],"we":[271,324],"assessed":[272],"whether":[273],"activity":[276],"contrast":[287],"anti-CSF1R":[290],"antibody":[291],"did":[292],"induce":[294],"significant":[296],"delay":[297],"growth.":[301],"These":[302],"results":[303],"confirm":[304],"has":[307],"pleiotropic":[308],"system":[313],"modulation":[315],"mechanisms.":[321],"summary,":[323],"propose":[325],"plays":[328],"central":[330],"role":[331],"inducing":[333],"suppression":[335],"microenvironment":[339,400],"by":[340,381],"inhibiting":[342],"T":[343],"cells":[344],"supporting":[346],"viability":[348,442],"pro-tumorigenic":[350],"Thus,":[352],"represents":[355],"novel":[357],"investigational":[358],"strategy":[359],"dual":[361],"activity:":[362],"cancer":[366],"certain":[370],"tumors":[371],"well":[373],"promotion":[375],"an":[377],"transformation":[383],"microenvironment.":[388],"Tumors":[389],"are":[391],"intrinsically":[392],"dependent":[393],"exhibit":[397],"myeloid-rich":[399],"could":[401],"be":[402],"particularly":[403],"susceptible":[404],"this":[406],"dual-mechanism":[407],"therapeutic":[408],"strategy.Citation":[409],"Format:":[410],"Elsa":[411],"Quintana,":[412],"Chris":[413],"J.":[414,417],"Schulze,":[415],"Tiffany":[416],"Choy,":[418],"Darienne":[419],"R.":[420],"Myers,":[421],"Kasia":[422],"Mordec,":[423],"Dylan":[424],"Daniel,":[425],"Mark":[426],"A.":[427,430],"Goldsmith,":[428],"Jan":[429],"Smith.":[431],"Allosteric":[432],"suppresses":[436],"reduces":[441],"contributing":[448],"[abstract].":[452],"In:":[453],"Proceedings":[454],"American":[457],"Association":[458],"for":[459],"Cancer":[460,474],"Research":[461],"Annual":[462],"Meeting":[463],"2019;":[464],"2019":[465],"Mar":[466],"29-Apr":[467],"3;":[468],"Atlanta,":[469],"GA.":[470],"Philadelphia":[471],"(PA):":[472],"AACR;":[473],"Res":[475],"2019;79(13":[476],"Suppl):Abstract":[477],"nr":[478],"5019.":[479]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-12T00:00:00"}